These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 1798713)

  • 1. [Pharmacokinetics of bendamustin (Cytostasan) in B6D2F1-mice].
    Weber H; Amlacher R; Preiss R; Hoffmann H
    Pharmazie; 1991 Aug; 46(8):589-91. PubMed ID: 1798713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of leukemia P388 on plasma concentration-time profiles of bendamustine in B6D2F1 mice.
    Amlacher R; Weber H; Preiss R; Hoffmann H
    Pharmazie; 1992 May; 47(5):378-81. PubMed ID: 1409829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatobiliary elimination of bendamustin (Cytostasan) in rats.
    Bezek S; Scasnár V; Trnovec T; Grupe R
    Pharmazie; 1991 Nov; 46(11):810-1. PubMed ID: 1811234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and systemic bioavailability of menogaril, an anthracycline antitumor agent, in the mouse, dog, and monkey.
    Adams WJ; McGovren JP; Dalm EA; Brewer JE; Hosley JD
    Cancer Res; 1989 Nov; 49(22):6328-36. PubMed ID: 2529962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of oral [14C]cefcanel daloxate hydrochloride in healthy male subjects.
    Edwall B; Arvidsson A; Lake-Bakaar D; Lanbeck-Vallén K; Yisak W
    Drug Metab Dispos; 1993; 21(1):171-7. PubMed ID: 8095213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccinium myrtillus anthocyanosides pharmacokinetics in rats.
    Morazzoni P; Livio S; Scilingo A; Malandrino S
    Arzneimittelforschung; 1991 Feb; 41(2):128-31. PubMed ID: 2043174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics of 3H-bamethan in humans].
    Hengstmann JH; Steinkamp B
    Arzneimittelforschung; 1981; 31(5):843-8. PubMed ID: 6115653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption, disposition, and metabolism of [14C]didanosine in the beagle dog.
    Kaul S; Shyu WC; Shukla UA; Dandekar KA; Barbhaiya RH
    Drug Metab Dispos; 1993; 21(3):447-53. PubMed ID: 8100500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
    Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
    Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent.
    Aneja R; Dhiman N; Idnani J; Awasthi A; Arora SK; Chandra R; Joshi HC
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):831-9. PubMed ID: 17285314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic study of intravenous and oral idarubicin in cancer patients.
    Tamassia V; Pacciarini MA; Moro E; Piazza E; Vago G; Libretti A
    Int J Clin Pharmacol Res; 1987; 7(5):419-26. PubMed ID: 3478310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zidovudine bioavailability and linear pharmacokinetics in female B6C3F1 mice.
    Trang JM; Prejean JD; James RH; Irwin RD; Goehl TJ; Page JG
    Drug Metab Dispos; 1993; 21(1):189-93. PubMed ID: 8095218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
    Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP technical report on the toxicity studies of p-tert-butylcatechol (CAS No. 98-29-3) administered in feed to F344/N rats and B6C3F1 mice.
    Dunnick J
    Toxic Rep Ser; 2002 Nov; (70):5-51. PubMed ID: 12592414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of 9-methoxy-N,N-dimethyl-5-nitropyrazolo [3,4, 5-kl]acridine-2(6H)-propanamine (PZA, PD 115934, NSC 366140) in mice: guidelines for early clinical trials1.
    Foster BJ; Wiegand RA; LoRusso PM; Baker LH
    Clin Cancer Res; 1995 Aug; 1(8):831-7. PubMed ID: 9816052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
    Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG
    Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I study of bendamustine hydrochloride administered once every 3 weeks in patients with solid tumors.
    Rasschaert M; Schrijvers D; Van den Brande J; Dyck J; Bosmans J; Merkle K; Vermorken JB
    Anticancer Drugs; 2007 Jun; 18(5):587-95. PubMed ID: 17414628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of the new fluoroquinolone balofloxacin in mice, rats, and dogs.
    Nakagawa T; Ishigai M; Kato M; Hayakawa N; Kinoshita H; Okutomi T; Ohkubo K; Okazaki A
    Arzneimittelforschung; 1995 Jun; 45(6):719-22. PubMed ID: 7646579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The pharmacokinetics of bendamustine (Cytostasane) in humans].
    Preiss R; Sohr R; Matthias M; Brockmann B; Hüller H
    Pharmazie; 1985 Nov; 40(11):782-4. PubMed ID: 4095129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High performance liquid chromatographic analysis and preclinical pharmacokinetics of the heteroarotinoid antitumor agent, SHetA2.
    Zhang Y; Hua Y; Benbrook DM; Covey JM; Dai G; Liu Z; Chan KK
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):561-9. PubMed ID: 16534614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.